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Abstract
The dietary approaches to stop hypertension (DASH) 
diet has been developed and popularized as a non-
pharmaceutical intervention for high blood pressure 
reduction since 1995. However, to date, a compre-
hensive description of the biochemical rationale behind 
the diet’s principal guidelines has yet to be compiled. 
With rising interest for healthy and reliable life-style 
modifications to combat cardiovascular disease, this 
review aims to compile the most recent and relevant 
studies on this topic and make an informed assess-
ment as to the efficacy of and underlying mechanisms 
operant in the DASH diet. Specifically, the merits of 
lowering dietary intake of sodium and saturated fat, as 
well as increasing the intake of fruits, vegetables, fiber, 
and dairy, have been shown to attenuate hypertension 
individually. Upon review of this evidence, we conclude 
that the combination of dietary patterns proposed in the 
DASH diet is effective in attenuating high blood pressure. 
We also suggest that efforts to more widely implement 
adoption of the DASH diet would be beneficial to public 
health. 
Key words: Dietary approaches to stop hypertension 
diet; Hypertension; Salt restriction; Oxidative stress; 
Biochemistry
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: As a non-pharmaceutical intervention for 
hypertension, the dietary approaches to stop hyper-
tension (DASH) diet have emerged as the most prevalent 
choice. Based on the principles of salt restrictions, 
lowering fat and sugar intake, increasing fruit, vegetable, 
and fiber intake, this program serves great promise 
for patients diagnosed with high blood pressure. This 
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review aimed to assess the biochemical rational behind 
the diet’s principle guidelines to evaluate the efficacy 
of the DASH diet in the treatment of hypertension. We 
conclude that the combined tenets of the DASH diet are 
effective in lowering blood pressure.
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INTRODUCTION
Currently suspected as an underlying cause of ap­
proximately 7.1 million (13% of) deaths worldwide, 
hypertension remains a prevalent affliction[1]. To com­
plicate the matter, the etiology of primary (essential) 
hypertension which accounts for 90%­95% of adult 
cases is still unclear[2]. Uncontrolled hypertension serves 
to be a major risk factor for the development of a 
multitude of neural[3], cardiac[4], and renal[5] disorders. 
Similar to the “All roads lead to Rome” adage, several 
factors have been implicated in the pathogenesis of 
hypertension including, but not limited to: Oxidative 
stress, genetic factors, renal injury, inadequate nutrient 
intake, overproduction of sodium retaining hormones, 
disruption of the renin­angiotensin or kallikrein­kinin 
systems, deficiencies in vasodilators[6]. This review 
utilized studies dating back to the early 1900’s in order to 
establish a background for the research being conducted 
today, however, the majority of data compiled for review 
in this paper was conducted from the INTERSALT study[7] 
in 1988 through present day.
Until recently, hypertension has been classified into 
three stages that increase in severity: Pre­hypertension, 
[systolic blood pressure (BP) of 120­139 mmHg and 
diastolic BP of 80­89 mmHg], stage 1 (systolic BP of 
140­159 mmHg and diastolic BP of 90­99 mmHg), and 
stage 2 (systolic BP of 160­179 mmHg and diastolic 
BP of 90­99 mmHg). These classifications arose in 
2003 with the 7th JNC report on hypertension[8]. More 
recently in 2014, the 8th JNC report was released to the 
public. The 8th edition of the report modified the above 
specifications, and took an alternate approach regarding 
the BP threshold of intervention, which treatment should 
be administered, and also the target BP to be achieved. 
JNC 8 proposes to begin treatment for those over the age 
of 60 at an increased BP threshold of > 150/90 mmHg, 
while the goal BP for those below the age of 60 is still < 
140/90[9]. The change originated from multidisciplinary 
analysis of many randomly controlled trial studies. The 
idea behind this decision was based on the reevaluation 
of the risks of side effects vs the benefits of treatment of 
hypertension[9]. A great deal of controversy has arisen 
surrounding the 8th JNC report, some dissent arising 
from the JNC panel itself. In a paper published shortly 
after the JNC 8, Wright et al[10] cited insufficient evidence 
for increasing the benchmark of treatment in patients 
over 60, proposing that the goal BP eligible for treatment 
should be lowered. Wright et al[10] argued that increasing 
the benchmark BP of this age group would also increase 
the group’s risk of cardiovascular disease (CVD), 
especially in high risk populations, and would undo the 
progress of steadily decreasing levels of cardiovascular 
mortality. The team proposed that it would be more 
appropriate to raise the BP threshold for treatment 
in individuals aged 80 and above, as the benefits of 
therapy would be far more likely to exceed the risks[10]. 
For the purpose of this review, we refer to JNC 7 stages 
of hypertension, due to the vast majority of research 
published before the presentation of the new guidelines. 
To help manage and attenuate disease pathogenesis, 
intervention by way of lifestyle modification and/or 
pharmaceutical therapies are strongly recommended. 
However, due to the economic burden and potential 
adverse side effects associated with pharmaceutical 
therapies, a growing demand for alternate means of 
treatment quickly arose. Consequently, before the turn of 
the century, a dietary plan known as dietary approaches 
to stop hypertension (DASH) was publicized after 
successful results following two multicenter, randomized 
outpatient feeding studies[11­13]. The principal guidelines of 
the DASH diet[14] (depicted in Table 1) focus on increased 
consumption of fruits, vegetables, whole grains, fish, 
poultry, beans, and seeds; in addition to consuming 
low­ and non­fat dairy products, the diet calls for limited 
intake of: Sodium, saturated and trans fats, sugar, and 
red meat. This diet further encourages consumption of 
mineral­rich foods containing potassium, calcium, and 
magnesium, and foods rich in fiber. 
This review aims to breakdown and examine the 
biochemical rationales behind specific tenets of the 
DASH diet in an effort to evaluate its efficacy.
DIeTaRy SODIUm ReSTRICTION
Sodium plays an integral role in the biomechanical 
function of muscle and nerve fibers, and is largely 
responsible for the auto regulation of fluid balance at 
the cellular level. Yet, similar to other essential nutrients, 
excessive sodium levels can yield damaging effects 
physiologically. Research has delved into the relationship 
between sodium intake and hypertension for the past 50 
years, and it is widely regarded as a major component 
to the development of high BP[15]. Investigators Ambard 
et al[16] first evidenced this relationship in 1904, in which 
six hypertensive patients were placed on three separate 
diets with modified salt and protein content. Outcomes 
of the study revealed that sodium content, irrespective 
of protein content, was inversely related to BP within and 
across each diet. Specifically, when sodium intake was 
reduced, corresponding decreases in BP were observed.
Similar beneficial effects of dietary sodium restriction 
were reported in 1948, when Walter Kempner’s Rice 
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Diet became publicized. The initial study involved 500 
hypertensive patients placed on a diet predominantly 
consisting of rice, supplemented with fruits. Dietary 
salt content was maintained below 500 mg, and the 
subsequent effects of the diet were tremendous; along 
with attenuation of high BP, the patients’ demonstrated 
reduced cardiac hypertrophy and amelioration of 
hypertensive retinopathy[17]. Although the practicality of 
maintaining this fairly tasteless diet proved bleak, the 
implications of the study were inescapable. 
More recently, in 1980 Srinivasan et al[18] tested 
the effects of a high salt vs high salt/sucrose diets on 
spider monkeys. Findings from the study indicated that 
both high salt and high salt/sucrose diets resulted in 
elevated BP, and most importantly, in a dose­dependent 
manner[18]. In 1988, the monumental Intersalt study 
was compiled. Examining approximately 10000 patients 
from 52 examination centers worldwide, Intersalt 
remains the largest study of its kind to date. The major 
findings extended over international population and 
individual levels, and supported the direct correlation 
between sodium intake and hypertension. Regional 
differences in salt intake were also found to correlate 
with regional levels of hypertension. Perhaps of even 
greater relevance, the increases in systolic BP noted with 
age appeared to correlate on a population level even 
better with sodium intake than absolute levels of BP[7].
Although the relationship between salt and BP is 
readily accepted, the exact biochemical mechanism 
behind salt’s role in the development of hypertension 
remains unclear. The renal renin­angiotensin­aldosterone 
system (RAAS) appears to be largely implicated in the 
development of salt driven hypertension and is the 
site of many pharmacological treatments for stage 2 
hypertension, including angiotensin­converting enzyme 
(ACE) inhibitors and angiotensin Ⅱ (Ang Ⅱ) receptor 
blockers[19]. 
Under physiological conditions, high salt diets typically 
suppress Ang Ⅱ levels through BP control mechani­
sms[20]. Despite this, 40%­50% of patients with essential 
hypertension do not engage this expected renal response 
to Ang Ⅱ and thus, do not react appropriately to changes 
in dietary sodium intake (depicted in Figure 1)[20,21]. This 
is one avenue of salt sensitivity, and while it has been 
documented clinically, its mechanisms have yet to be 
resolved[22,23]. Salt sensitivity has also been attributed to 
genetic mutations of the renin and ACE genes[24]. These 
individuals appear to exhibit high BP and low plasma 
renin levels in response to salt intake[25]. 
Additionally, RAAS, nitric oxide (NO), and superoxide 
anion (O2­) in the kidney, work together in a regulatory 
fashion. Activation of RAAS leads to the production of 
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Table 1  Breaking down the dietary approaches to stop 
hypertension diet 
Food group Daily servings Nutritional value
Grains/dietary fiber 7-8 Rich in dietary fiber
Vegetables 4-5 Rich in nitrate, fiber, potassium, 
and magnesium
Fruits 4-5 Rich in nitrate, fiber, potassium, 
and magnesium
Protein (poultry, fish, 
etc.)
2-5 High in bioactive proteins and 
magnesium
Low and non-fat dairy 2-3 High in calcium, vitamin D, and 
bioactive proteins
Nuts, seeds, and dry 
beans
4-5 High in potassium, magnesium, 
proteins, and fiber
Fats and oil 2-3 Accounts for 27% of caloric 
intake and essential fats and oils
Sugar 5 per week Sweets should be low in fat
A breakdown of the dietary approaches to stop hypertension (DASH) diet 
by food group, serving size per diem, and the nutritional goal of each of 
the DASH guidelines. These specific guidelines have been endorsed and 
published by the National Institutes of Health[14].
Increased sodium intake
Sodium homeostasis
Decreased SNS activity
Decreased RAAS activity
Increased natriuretic peptides
Increase in CTS 
Shift in salt sensitivity
Volume expansion
Hypertension
Increased oxidative stress
Renal fibrosis
Upregulation of AT2 and Aldo receptors
Upregulation of alpha adrenergic receptors
Figure 1  Schematic summarizes tradeoff by which physiological mechanisms that lead to sodium homeostasis in face of increased sodium intake might, 
over time, lead to a shift in salt sensitivity and sustained hypertension. SNS: Sympathetic nervous system; RAAS: Renin, angiotensin, aldosterone, system; 
CTS: Cardiotonic steroids; AT2: Angiotensin Ⅱ; Aldo: Aldosterone.
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effeCTS Of INCReaSINg fRUIT aND 
VegeTable INTake
As discussed above, the origin and development of 
hypertension is complex, yet substantial literature also 
suggests that a sustained increase in peripheral vascular 
resistance due to arterial structural remodeling plays a 
prominent role in the pathogenesis of this disease[6,35,36]. 
Research suggests that the high inorganic nitrate (NO3­) 
content present in many vegetables may play vasopro­
tective[37­39] and cardioprotective[40] roles, via endogenous 
conversion to NO ­ a potent vasodilator. Consequently, 
endothelial dysfunction often characterized by a 
reduction in NO bioavailability has been largely implicated 
in patients with essential hypertension[41­43]. Discussion 
considering the physiological biosynthesis and function of 
NO can be found in several references[40,44­48]. 
It is estimated that the largest source of dietary 
nitrates (roughly 80%) comes directly from vegetable 
consumption; alternate dietary sources of nitrate and 
nitrite (a reduced form of nitrate) can also be found in 
fruits, vegetables, and processed meats[38]. In 2008, 
Webb et al[37] provided the first clinical evidence support­
ing the vasoprotective role of dietary nitrate harbored 
by a vegetable­rich diet in normotensive volunteers. The 
team of researchers utilized beetroot juice to display that 
consumption of an acute nitrate load corresponds with 
a significant reduction of both systolic and diastolic BP, 
as well as a reduction of platelet activation; these effects 
appear to be associated with the simultaneous rise in 
circulating nitrite levels[37] via entero­salivary conversion 
of the original dietary nitrate load, and further reduction 
of nitrite to NO[37,49,50].
The DASH diet calls for 4­5 servings of fruits and 
4­5 servings of vegetables per day (based on a 2000 
calorie diet); the range of daily servings per food group 
may fluctuate depending on an individual’s daily caloric 
needs, which take one’s age and activity level into 
account[14]. In response to the substantial literature 
present supporting the physiological benefits of dietary 
nitrate and nitrite, Hord et al[38] extended these findings 
to assess the high fruit and vegetable recommendations 
emphasized by the DASH diet. The researchers utilized 
High­performance liquid chromatography (HPLC) on a 
convenience sample of foods in order to quantify and 
compare various nitrate and nitrite concentrations. 
Results from HPLC indicated a wide range of nitrate and 
nitrite content amongst various fruits and vegetables. 
From this data, the researchers generated two hypo­
thetical high­ and low­nitrate vegetable and fruit DASH 
diet patterns (i.e., 1222 mg nitrate vs 174 mg); the 
analysis revealed that the general dietary pattern of 
fruits and vegetables outlined in the DASH guidelines 
have the potential to vary drastically in terms of nitrate 
intake, based on specific vegetable and fruit selection[38]. 
The results further suggest that simply increasing fruit 
and vegetable intake does not directly translate to 
O2­, a vasoconstrictor, and NO, a vasodilator, and both 
molecules readily react with one another. Dysfunction 
within the RAAS can lead to an imbalance of NO and 
O2­, which has been linked to salt sensitivity and hyper­
tension[26,27]. In short, high levels of dietary sodium 
appear to induce inappropriate RAAS activity, leading 
to vascular maladaptation[28]. While certainly not the 
only avenue of hypertension, these studies highlight 
the importance of the RAAS in management of hyper­
tension.
Sustained levels of high dietary sodium intake have 
been implicated not only in the pathogenesis of hyperten­
sion, but also albuminuria, altered gene expression, and 
even renal structural damage[29]. Further experiments 
have been crafted to test the efficacy of lowering 
sodium intake on hypertensive patients. He et al[30] 
demonstrated that a diet modified to lower only sodium 
content, with no other dietary restrictions, caused a 
significant reduction in BP in both normotensive and 
hypertensive patients. Moreover, as recently as 2015, a 
study conducted by Barros et al[31] highlighted the use of 
“light salt”, a salt developed with lower sodium content 
and higher potassium levels as a significantly effective 
agent in reducing BP. 
The first major tenet of the DASH diet is a substantial 
reduction in sodium intake[11]. It is estimated that the 
average adult American consumes roughly 3700 mg of 
sodium per day; by contrast, the DASH diet recommends 
that dietary sodium should be limited to < 2300 mg/d 
(< 1500 mg/d for high­risk individuals)[32]. In a com­
prehensive analysis of the effect of sodium consumption 
on BP, Bray et al[33] evaluated variations of sodium intake 
within the context of the standard American diet vs the 
DASH diet. In total, the study consisted of six groups: A 
control diet similar to the standard American diet and a 
DASH diet group were each divided into low, moderate, 
and average (high) sodium groups[33]. The researchers 
demonstrated a dose­dependent relationship between 
sodium consumption and BP; the findings corresponded 
with the results of previous experiments (discussed 
above): The lower the sodium intake, the greater the 
drop in BP. Furthermore, while both control and DASH 
groups experienced a drop in BP, limiting dietary sodium 
had an additive relationship when coupled with the DASH 
diet; these results demonstrate that patients consuming 
lower dietary sodium, in accompaniment with the rest of 
the DASH dietary patterns, experience an even greater 
drop in BP[30,33]. Biochemical analysis of the DASH diet 
yield similar optimistic results. Using the same six­group 
approach as Bray et al[33], analysis was performed by 
examining their corresponding pressure­natriuresis 
curves. The DASH diet appeared to decrease tubular 
sodium reabsorption without increasing glomerular 
filtration rate[34]; thus, the DASH diet is natriuretic in a 
sustainable way. Compiling the evidence­based research 
together, as a whole, we find overwhelming support of 
sodium restriction aiding the efficacy of the DASH diet in 
controlling hypertension.
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higher dietary nitrate and nitrite consumption, this may 
alter the extent of vasoprotective and cardioprotective 
implications mediated by these molecules (as discussed 
above).
In the pathologic state, increasing evidence implicates 
oxidative stress to largely influence the induction and pro­
gression of hypertension[51]. The unregulated production 
of reactive oxygen species (ROS) can largely disrupt 
function of essential cellular lipids and proteins[52,53]. Accor­
dingly, several natural antioxidant components of fruits 
and vegetables (i.e., vitamins, minerals, polyphenols) 
are shown to assist the bodies’ ROS scavenging system 
via multiple mechanisms, and are greatly implicated in 
controlling high BP and endothelial dysfunction[54­56]. The 
rich vitamin and mineral content found within fruits and 
vegetables contribute to both the enzymatic and non­
enzymatic (direct ROS scavengers) antioxidant defense 
systems[57]. In regards to enzymatic ROS quenching, 
many of these enzymes exist as metalloenzymes. 
Three isoforms of superoxide dismutase help confer 
vascular protection as potent defenders of superoxide via 
dismutation[58], and utilize metals such as zinc, copper, 
and manganese. Additionally, glutathione peroxidases 
readily quench reactive hydrogen peroxide (by product 
of previous reaction), and are selenium­dependent 
enzymes[57]. Fruits and vegetables are often great sources 
of these essential minerals, and thus can contribute to 
enzymatic ROS defense. 
In a similar vein, other micronutrients abundant in 
fruits and vegetables further bolster antioxidant defense 
by non­enzymatic means via direct scavenging of ROS. 
Lipid­soluble vitamin E and water­soluble vitamin C are 
both capable of reacting with peroxyl radicals[59]. It was 
later reported that vitamin E might synergistically interact 
with vitamin C in order to enhance its role as a peroxyl 
radical scavenger[60]. Additionally, Pierdomenico et al[61] 
observed drastically reduced plasma levels of vitamin C 
in hypertensive patients compared to their normotensive 
counterparts. Subsequently, Block et al[62] supported this 
observation by demonstrating that vitamin C depletion 
in normotensive subjects resulted in increased diastolic 
and systolic BP[62]. However, it should be noted that 
the relative antioxidant capacity[63] and content[64] of 
various constituents in fruits and vegetables is variable. 
This disparity is seen with plant­derived polyphenolic 
flavonoids, which are found to possess nearly four times 
the antioxidant activity than vitamin E analogue[63]. 
As of recent, fructose and its relation to BP has been 
a popular topic of contention. In the United States, 
this monosaccharide ­ naturally available in fruits ­ 
is most abundantly obtained from added fructose­
glucose sweeteners such as, table sugar (sucrose) and 
high­fructose corn syrup[65]. Although, high fructose 
consumption is evidenced to be associated with insulin 
resistance[66], obesity[67,68], and renal[69] complications, 
epidemiological studies are controversial[70­72]; moreover, 
the source of dietary fructose may be of importance. 
The rich antioxidant properties associated with fruits 
(discussed above) may counter the potential harmful 
effects suggested by fructose. While this relationship or 
mechanism has yet to be established, Forman et al[70] 
found no association with fructose consumption and 
hypertension, in which individuals consumed a high 
intake of fruits. Excluding fructose content from natural 
fruit, a 2010 cross sectional analysis of United States 
adults with no prior history of hypertension reported an 
independent association between high fructose intake 
(from added sugar) and elevated BP[71]. Cumulatively, 
the multitude of micronutrients found in fruits and 
vegetables (as evidenced above) make them a beneficial 
and necessary inclusion in the major tenets of the DASH 
diet program.
beNefITS Of faT-fRee aND lOw-faT 
DaIRy PRODUCTS
Dairy products and fatty acids are closely intertwined 
biochemically, and comprise one of the major tenets of 
the DASH diet program. The effect of saturated fats on 
BP has been a popular research topic during the last 
twenty years. It has been observed that populations 
consuming diets low in both total and saturated fats, 
are often the ones exhibiting low to moderate BPs[73]. 
Analysis of three vegetarian diets: the first consisting 
of high carbohydrates and low fat, the second high in 
polyunsaturated fat, and the third low in saturated fat 
content, revealed that all conditions were shown to 
reduce BP in their respective populations[73­75]. Further 
support for the relationship between dietary saturated fat 
content and BP was demonstrated by a study compiled 
in Finland; the experimental group that consumed high 
levels of saturated fats subsequently had higher BP than 
their control counterparts[76,77]. 
Unlike saturated fatty acids, diets high in polyun­
saturated fats[78] and monounsaturated fats[79] have 
been shown to have an inverse relationship with BP. 
Fish oil, high in polyunsaturated fat, has been shown to 
have protective effects against the risk factors for CVD, 
including hypertension[80]. The fatty acids found in fish 
oil are precursors for 3­series prostaglandins, known 
for their antiaggregatory and vasodilator properties[81]; 
furthermore, polyunsaturated fats (such as linoleic acid 
and those found in fish oil) have been shown to lower 
low­density lipoprotein (LDL) cholesterol levels. This is 
vitally important in protection against CVD because the 
oxidized form of LDLs are absorbed by macrophages, 
creating foam cells that latch onto the walls of arteries, 
leading to atherosclerosis[82]. Frenoux et al[81] study 
went on to show that polyunsaturated fatty acids had 
antihypertensive effects, and also boosted resistance to 
free radical aggregation and lipid peroxidation.
Dairy, in contrast, consists of a more complex makeup 
of constituents: 89% water, 3.5% protein, 4.6% car­
bohydrates, and 3.3% lipid[83]. The protein constituents in 
dairy products are made up of bioactive peptides, known 
as lactotripeptides[84], and are similar to those found in 
lean red meat; both varieties of bioactive peptides have 
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been shown to block ACE[85]. The lipid components of 
dairy products generally consist of about 60% saturated 
fatty acids (FA) and about 30% unsaturated FA[86]. The 
other about 10% consist of short to medium length FA 
chains that are readily absorbed into the bloodstream, 
where they preferentially become oxidized rather than 
stored as triglycerides; and, in short, is associated with 
weight loss[86,87]. An inverse relationship was found to 
exist between dairy intake and BP; and, this relationship 
was strengthened if saturated fat intake was below about 
11%[88]. 
Additionally, dairy intake, while not associated with 
overall mortality, appears to be inversely related to the 
multitude of risk factors for CVD including hyperten­
sion[89]. More recently, Drouin­Chartier et al[84] reported 
dairy intake to improve endothelial function and attenuate 
mild to moderate hypertension. Subsequent studies 
have shown that vitamin D alone also displays a curative 
effect on hypertension and other CVD risk factors[90]. 
The body of evidence here supports the DASH diet’s 
recommendations in emphasizing the consumption of fat­
free and low­fat dairy products, as well as reducing the 
intake of saturated and trans fats.
RICH eNeRgy SOURCeS: wHOle 
gRaINS aND DIeTaRy fIbeR
Dietary fiber is the indigestible cell wall component found 
in plants[91]. It is divided into two categories, soluble fiber 
and insoluble fiber. Soluble fibers include pectins, gums, 
mucilages, and some hemicelluloses; alternatively, insolu­
ble fibers include lignins, cellulose, and the remainder 
of the hemicelluloses[92]. Early studies, conducted by 
Burkitt[93] in 1975, demonstrated that low dietary fiber 
intake is linked to many diseases, such as cardiovascular 
disease. This lent credence to the idea that dietary 
fiber may also be related to hypertension, a major risk 
factor in CVD. The recommended daily intake value of 
dietary fiber is between 20­35 g/d[94]. This is twice the 
amount of fiber that the average American typically 
consumes[95]. Initially, studies sought to analyze high­
fiber vegetarian diets, which were previously shown to 
attenuate hypertension[91]. Subsequently, there was a 
rise in controversy; critics suggested that the decrease 
in BP seen in these studies could have easily arisen 
from other factors present in a vegetarian diet. Another 
setback arose with the discovery that increases in 
dietary fiber alone had little to no effect on normotensive 
patients[96]. 
Despite these setbacks, new research emerged 
showing the benefits of dietary fiber in regards to cardiac 
distress. In 1997, Stamler et al[97] demonstrated an 
inverse relationship between increased dietary fiber 
intake and BP. Additionally, whole grains were shown 
to be associated with lowering BP[98]. Whole grains 
themselves offer much nutritional value, providing 
complex carbohydrates, resistant starch, dietary fiber, 
minerals, vitamins, phytochemicals (which serve as 
antioxidants) and other nutrients[99,100]. A 4­fold decrease 
was seen in the cardiovascular death rate between men 
who ingested a high fiber diet (> 37 g/d) vs those who 
ingested a low fiber diet (< 20 g/d)[101]. Similar results 
were demonstrated, during a 6­year prospective study, in 
which an inverse relationship was found between dietary 
fiber intake and CVD rates[102]. Additionally, cereal fiber 
was revealed to be strongly associated with a reduction 
in CVD death rates; this result was further supported by 
the documented protective nature of whole grains[103,104]. 
Adding support to the inverse relationship between 
dietary fiber and cardiovascular risk factors, Lairon et 
al[105] further demonstrated that this correlation existed 
for all forms of fiber (Soluble, insoluble, fruits, grains, 
vegetables, cereal, etc.), specifically in regards to the 
prevalence of hypertension. While mechanistic data 
is yet to be confirmed, it is thought to be associated 
with a reduction of abdominal obesity and increased 
vascular reactivity[105]. Fiber has also been shown to 
attenuate endothelial dysfunction associated with hyper­
cholesterolemia[106]; this finding suggests that fiber may 
indirectly play a protective role against hypertension, 
as the endothelium serves as an important regulator 
of vascular tone in response to altering needs for blood 
amongst different organs and tissues[107,108]. Taken 
together, a substantial body of evidence suggests that 
increasing dietary fiber plays a beneficial role in the 
battle against hypertension.
CONClUSION
The DASH diet has provided the general public with a 
non­pharmaceutical option to combat hypertension. The 
last twenty years have been filled with studies breaking 
down each aspect of the DASH program. Many of these 
studies showed great success in highlighting the benefits 
of lowering sodium and saturated fat intake, while 
increasing intake of fruits, vegetables, dairy, and dietary 
fiber. However, the biochemical mechanisms behind these 
dietary guidelines have only been vaguely illuminated. 
Dietary biochemistry itself is a very complex story to tell, 
consisting of a diverse array of mechanistic pathways 
and byproducts. Although a complete understanding of 
each of these mechanisms and their implications has not 
yet been established, substantial effort has been made 
to fill in the gaps. This review attempted to compile the 
most recent available research in order to paint as vivid 
a picture as possible of how individual aspects of the 
DASH diet effect BP, and ultimately draw a conclusion 
as to the efficacy of such a diet for the treatment of 
hypertension. Despite the limitations of the total scope of 
our analysis, the abundant evidence in support of these 
dietary modifications is compelling, and we recommend 
the DASH diet to be an effective non­pharmaceutical 
treatment of hypertension. Further publicity and 
implementation could dramatically reduce the number 
of hypertensives both nationally and internationally. 
In American culture, focus should be placed on the 
maintainability of the diet. Stigmata has been placed 
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on healthy diets for being overly expensive, and out of 
reach for the average family. According to Sacks et al[109], 
the DASH program should cost approximately $130.00 
per week for a family of 4. Adjusting for inflation, this 
translates to less than $200.00 per week today, still a 
very low total for a family of 4. Internationally, focus 
should be shifted to modification of diets depending on 
the cultural tendencies of the various groups of people 
who are regionally predisposed to high salt diets. These 
actions taken together could have a great impact on the 
health of individuals worldwide. Future research will need 
to elucidate the biochemical mechanisms inherent in 
the DASH diet. This could lead to further, more tailored 
and effective, dietary modifications for the masses; we 
predict that as further comprehensive understanding of 
this anti­hypertensive diet grows, we will see an overall 
attenuation of this disease.
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